Correction

Scavenger receptor collectin placenta 1 is a novel receptor involved in the uptake of myelin by phagocytes (vol 7, 44794, 2017)

Journal

SCIENTIFIC REPORTS
Volume 7, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep46925

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

Article Biochemical Research Methods

Switching positions: Assessing the dynamics of conjugational heterogeneity in antibody-drug conjugates using CE-SDS

Eline B. A. van den Berg, Jaap C. W. Hendriks, Everdine W. Elsinga, Mark Eggink, Eef H. C. Dirksen

Summary: Antibody-drug conjugates (ADCs) are a promising class of oncology therapeutics that can deliver cytotoxic drugs to specific locations. This study investigated the impact of disulfide bond reduction time on drug load and isomers of ADCs, revealing a dynamic relationship between them.

ELECTROPHORESIS (2023)

Article Medicine, Research & Experimental

Increased methylglyoxal formation in plasma and tissues during a glucose tolerance test is derived from exogenous glucose

Xiaodi Zhang, Jean L. J. M. Scheijen, Coen D. A. Stehouwer, Kristiaan Wouters, Casper G. Schalkwijk

Summary: In this study, we found that the formation of postprandial methylglyoxal (MGO) in plasma and tissues originates from exogenous glucose and the increase in plasma MGO concentration leads to a fast formation of MGO-derived advanced glycation endproducts (AGEs).

CLINICAL SCIENCE (2023)

Article Biochemistry & Molecular Biology

Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases

Na Zhan, Boyang Wang, Nikita Martens, Yankai Liu, Shangge Zhao, Gardi Voortman, Jeroen Van Rooij, Frank Leijten, Tim Vanmierlo, Folkert Kuipers, Johan W. Jonker, Vincent W. Bloks, Dieter Luetjohann, Marcella Palumbo, Francesca Zimetti, Maria Pia Adorni, Hongbing Liu, Monique T. Mulder

Summary: The study identified five novel LXR-activating 24-oxidized sterols with potential therapeutic applications in neurodegenerative and cardiovascular diseases. These compounds demonstrated high potency for LXR alpha/beta activation and induced the expression of LXR-target genes involved in cellular cholesterol turnover. They also enhanced cholesterol efflux and upregulated the production of endogenous LXR agonists. Overall, these findings suggest the potential of developing compounds targeting LXR for the treatment of lipid-related diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Sterol-regulated transmembrane protein TMEM86a couples LXR signaling to regulation of lysoplasmalogens in macrophages

Suzanne A. E. van Wouw, Marlene van den Berg, Maroua El Ouraoui, Amber Meurs, Jenina Kingma, Roelof Ottenhoff, Melanie Loix, Marten A. Hoeksema, Koen Prange, Gerard Pasterkamp, Jerome J. A. Hendriks, Jeroen F. J. Bogie, Jan B. van Klinken, Frederic M. Vaz, Aldo Jongejan, Menno P. J. de Winther, Noam Zelcer

Summary: LXR transcription factors play an important role in regulating the composition of lipid species in cellular membranes, particularly lysoplasmalogens. This study identified TMEM86a as a sterol-regulated lysoplasmalogenase in macrophages, which contributes to sterol-dependent membrane remodeling. TMEM86a has been found to have lysoplasmalogenase activity and its overexpression reduces lysoplasmalogen abundance and membrane fluidity in macrophages.

JOURNAL OF LIPID RESEARCH (2023)

Article Multidisciplinary Sciences

Microglia regulate central nervous system myelin growth and integrity

Niamh B. B. McNamara, David A. D. Munro, Nadine Bestard-Cuche, Akiko Uyeda, Jeroen F. J. Bogie, Alana Hoffmann, Rebecca K. K. Holloway, Irene Molina-Gonzalez, Katharine E. E. Askew, Stephen Mitchell, William Mungall, Michael Dodds, Carsten Dittmayer, Jonathan Moss, Jamie Rose, Stefan Szymkowiak, Lukas Amann, Barry W. W. McColl, Marco Prinz, Tara L. L. Spires-Jones, Werner Stenzel, Karen Horsburgh, Jerome J. A. Hendriks, Clare Pridans, Rieko Muramatsu, Anna Williams, Josef Priller, Veronique E. E. Miron

Summary: This study reveals the crucial role of resident microglia in maintaining myelin health in the central nervous system. Microglia are involved in regulating myelin growth, preserving myelin integrity, and influencing cognitive function. Disruption of the TGF beta 1-TGF beta R1 axis is implicated in the mechanism underlying the loss of myelin health. The findings suggest that targeting microglia could be a potential therapeutic approach for conditions with dysregulated myelin growth and integrity.

NATURE (2023)

Review Endocrinology & Metabolism

Advanced glycation endproducts in diabetes-related macrovascular complications: focus on methylglyoxal

Casper G. Schalkwijk, Linda Renata Micali, Kristiaan Wouters

Summary: Diabetes is linked to vascular injury and the development of macrovascular complications. Advanced glycation endproducts (AGEs) and the precursor methylglyoxal (MGO) play important roles in connecting diabetes and vascular injury. While most studies have focused on the relationship between AGEs and vascular injury, the effects of MGO on vasculature are less understood. This review explores the mechanisms linking AGEs and MGO to the progression of atherosclerosis. AGEs and MGO are involved in various stages of atherosclerosis, but further research is needed to understand the exact underlying mechanisms. Nonetheless, targeting AGEs and MGO could provide therapeutic strategies for the macrovascular complications of diabetes.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2023)

Article Immunology

Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis

Melissa Schepers, Dean Paes, Assia Tiane, Ben Rombaut, Elisabeth Piccart, Lieve van Veggel, Pascal Gervois, Esther Wolfs, Ivo Lambrichts, Chiara Brullo, Olga Bruno, Ernesto Fedele, Roberta Ricciarelli, Charles Ffrench-Constant, Marie E. Bechler, Pauline van Schaik, Wia Baron, Evy Lefevere, Kobi Wasner, Anne Grunewald, Catherine Verfaillie, Paulien Baeten, Bieke Broux, Paul Wieringa, Niels Hellings, Jos Prickaerts, Tim Vanmierlo

Summary: Multiple sclerosis (MS) is a chronic autoimmune disease characterized by central nervous system inflammation and demyelination. Current therapies are insufficient in halting or reversing disease progression. This study shows that selective inhibition of phosphodiesterase 4 (PDE4) promotes myelin repair and reduces inflammation. Inhibition of PDE4D enhances (re)myelination, while inhibition of PDE4B exerts anti-inflammatory effects. These findings suggest that gene specific PDE4 inhibitors could be potential therapeutic agents for MS.

BRAIN BEHAVIOR AND IMMUNITY (2023)

Article Pharmacology & Pharmacy

Phosphodiesterase (PDE) 4 inhibition boosts Schwann cell myelination in a 3D regeneration model

Melissa Schepers, Afonso Malheiro, Adrian Seijas Gamardo, Niels Hellings, Jos Prickaerts, Lorenzo Moroni, Tim Vanmierlo, Paul Wieringa

Summary: Phosphodiesterase 4 (PDE4) inhibitors, such as roflumilast, have been extensively studied for their anti-inflammatory and neuroregenerative properties. This study found that roflumilast can promote differentiation of Schwann cells and accelerate myelination, as demonstrated in vitro using rat cells and a 3D co-culture model. These findings contribute to the development of PDE4 inhibition-based therapies in peripheral regenerative medicine.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Article Biochemistry & Molecular Biology

Therapeutic administration of mouse mast cell protease 6 improves functional recovery after traumatic spinal cord injury in mice by promoting remyelination and reducing glial scar formation

Tim Vangansewinkel, Stefanie Lemmens, Assia Tiane, Nathalie Geurts, Dearbhaile Dooley, Tim Vanmierlo, Gunnar Pejler, Sven Hendrix

Summary: In this study, researchers investigated the therapeutic potential of recombinant mMCP6 in improving functional outcomes after spinal cord injury. The findings suggest that mMCP6 can enhance recovery by reducing astrogliosis and promoting (re)myelination in the injured spinal cord.

FASEB JOURNAL (2023)

Review Biochemistry & Molecular Biology

Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury

Femke Mussen, Jana Van Broeckhoven, Niels Hellings, Melissa Schepers, Tim Vanmierlo

Summary: Traumatic spinal cord injury (SCI) is characterized by severe neuroinflammation and hampered neuroregeneration. Current therapies have limited effectiveness, so new strategies targeting the initial inflammatory reactions and promoting endogenous repair are crucial. Adenosine monophosphate (cAMP) regulates these processes and inhibiting its hydrolyzing enzyme phosphodiesterase (PDE) has shown promise in modulating inflammation and promoting regeneration. This review focuses on the immunomodulatory and neuroregenerative role of cAMP-specific PDE inhibition in SCI.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

Circulating and adipose tissue immune cells in tissue-specific insulin resistance in humans with overweight and obesity

Inez Trouwborst, Kristiaan Wouters, Johan W. Jocken, Kelly M. Jardon, Anouk Gijbels, Pieter C. Dagnelie, Marleen M. J. van Greevenbroek, Carla J. van Der Kallen, Coen D. A. Stehouwer, Casper G. Schalkwijk, Nathalie Richard, Igor Bendik, Lydia A. Afman, Ellen E. Blaak, Gijs H. Goossens

Summary: This study explored the relationships between adipose tissue and immune cells, gene expression, and inflammatory markers with liver and muscle insulin sensitivity in overweight and obese individuals. The findings revealed that specific immune cell populations and gene expression showed distinct associations with liver and muscle insulin sensitivity.

OBESITY (2023)

Article Cell & Tissue Engineering

Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing

David Diouf, Maria Rosaria Vitale, Johanna Eva Maria Zoeller, Ana -Magdalena Pineau, Eva Klopocki, Catharina Hamann, Georg Christoph Ziegler, Tim Vanmierlo, Daniel Van den Hove, Klaus-Peter Lesch

Summary: Fibroblasts from a healthy individual were infected with a Sendai virus to produce transgene-free human induced pluripotent stem cells (iPSCs) containing the Yamanaka factors. CRISPR/Cas9 was used to create an isogenic cell line with an inactivated ST3GAL3 gene, which is associated with neurodevelopmental and psychiatric disorders. This ST3GAL3 null mutant (ST3GAL3-/-) iPSC line, with pluripotency-associated marker expression, ability to differentiate into three germ layers in vitro, and normal karyotype, provides a powerful tool to study the impact of deficient glycoprotein sialylation in neural development and plasticity.

STEM CELL RESEARCH (2023)

Article Pharmacology & Pharmacy

Soluble guanylyl cyclase: A novel target for the treatment of vascular cognitive impairment?

Ellis Nelissen, Melissa Schepers, Laura Ponsaerts, Sebastien Foulquier, Annelies Bronckaers, Tim Vanmierlo, Peter Sandner, Jos Prickaerts

Summary: Vascular cognitive impairment (VCI) is a neurodegenerative disorder characterized by a vascular component, involving decreased cerebral blood flow, white matter lesions, endothelial dysfunction, and blood-brain barrier impairments. Oxidative stress and inflammation are major underlying mechanisms. Modulation of soluble guanylate cyclase (sGC) activity can improve vascular and neural function, and has shown efficacy in cardiovascular diseases.

PHARMACOLOGICAL RESEARCH (2023)

Meeting Abstract Medicine, Research & Experimental

Brain-penetrant sGC stimulator BAY-747 and activator runcaciguat act as cognitive enhancers via differential neuroplastic mechanisms

Ellis Nelissen, Tim Vanmierlo, Peter Sandner, Jos Prickaerts

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Meeting Abstract Medicine, Research & Experimental

sGC modulators as cognitive enhancers: neuronal and/ or vascular?

Jos Prickaerts, Ellis Nelissen, Tim Vanmierlo, Peter Sandner

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

No Data Available